Skip to Main Content

Paper Details

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.
Nat Med
104
2022
Author NameAffiliation
Keith A JohnsonMassachusetts General Hospital, Harvard Medical School
Keith A JohnsonCenter for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School
Keith A JohnsonAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School
Keith A JohnsonMassachusetts General Hospital, Harvard Medical School
Reisa A SperlingMassachusetts General Hospital, Harvard Medical School
Reisa A SperlingCenter for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School
Reisa A SperlingAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School
William J JagustLawrence Berkeley National Laboratory
William J JagustHelen Wills Neuroscience Institute, UC Berkeley
Ronald C PetersenMayo Clinic
Clifford R JackMayo Clinic
  • 1 - 11

Datasets